In his State of the Union Address earlier this month, President Joe Biden called for a $35 cap on insulin costs that are provided by insurance programs. This spring, the U.S. Senate is poised to lend its support to the plan that has already been approved by the U.S. House of Representatives.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,